ADMA Biologics, Inc.
ADMA
$17.10
-$0.20-1.16%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 90.29M | 71.63M | 103.15M | 86.71M | 88.24M |
| Total Receivables | 109.73M | 99.41M | 50.00M | 50.14M | 30.11M |
| Inventory | 191.46M | 172.19M | 170.24M | 171.80M | 179.81M |
| Prepaid Expenses | 8.09M | 8.59M | 8.03M | 9.55M | 5.52M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 399.56M | 351.81M | 331.41M | 318.19M | 303.69M |
|
|
|||||
| Total Current Assets | 399.56M | 351.81M | 331.41M | 318.19M | 303.69M |
| Net Property, Plant & Equipment | 66.46M | 65.73M | 63.34M | 62.59M | 63.48M |
| Long-term Investments | 3.53M | 3.53M | 3.53M | 3.53M | 3.53M |
| Goodwill | 3.53M | 3.53M | 3.53M | 3.53M | 3.53M |
| Total Other Intangibles | 527.00K | 452.00K | 460.00K | 485.00K | 479.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 88.30M | 89.04M | 89.94M | 5.82M | 5.22M |
| Total Assets | 558.38M | 510.57M | 488.68M | 390.62M | 376.40M |
|
|
|||||
| Total Accounts Payable | 29.77M | 20.61M | 20.22M | 16.02M | 14.18M |
| Total Accrued Expenses | 23.71M | 22.91M | 28.63M | 24.22M | 22.60M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.13M | 1.19M | 1.22M | 1.19M | 1.14M |
| Total Finance Division Other Current Liabilities | 20.33M | 8.79M | 5.48M | 3.46M | 6.26M |
| Total Other Current Liabilities | 20.33M | 8.79M | 5.48M | 3.46M | 6.26M |
| Total Current Liabilities | 74.94M | 53.50M | 55.54M | 44.89M | 44.18M |
|
|
|||||
| Total Current Liabilities | 74.94M | 53.50M | 55.54M | 44.89M | 44.18M |
| Long-Term Debt | 73.40M | 72.53M | 72.34M | 101.33M | 131.07M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 9.30M | 8.30M | 8.56M | 8.87M | 9.18M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.42M | 2.83M | 3.22M | 3.65M | 3.70M |
| Total Liabilities | 160.06M | 137.15M | 139.66M | 158.73M | 188.13M |
|
|
|||||
| Common Stock & APIC | 660.93M | 655.10M | 657.60M | 652.37M | 644.66M |
| Retained Earnings | -247.46M | -281.68M | -308.58M | -420.48M | -456.39M |
| Treasury Stock & Other | -15.15M | -- | -- | -- | -- |
| Total Common Equity | 398.33M | 373.42M | 349.02M | 231.89M | 188.27M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 398.33M | 373.42M | 349.02M | 231.89M | 188.27M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 398.33M | 373.42M | 349.02M | 231.89M | 188.27M |
|
|
|||||